Complex Coronary Cases Supported by: Abbott Vascular Boston Scientific Corporation Medtronic, Inc. Astrazeneca.

Slides:



Advertisements
Similar presentations
Complex Coronary Cases
Advertisements

Gerald S. Werner, MD, FESC, FACC Klinikum Darmstadt, Germany BSIC, Manchester, September 15, 2006.
CPORT- E Trial Randomized trial comparing medical, economic and quality of life outcomes of non-primary PCI at hospitals with and without on-site cardiac.
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs. Everolimus-Eluting Stents for Treatment of Unprotected Left Main Coronary Artery Lesions Julinda Mehilli,
29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
Debate #4: CTO Revascularization
Complex Coronary Cases Supported by: Abbott Vascular Boston Scientific Corporation Medtronic, Inc. Astrazeneca.
1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.
Qu Xinkai Shanghai Chest Hospital Shanghai Jiaotong University Value of comprehensive cardiac evaluation using MSCT in patients with CTO.
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Jie Qian National Heart Center & FuWai Hospitall FFR in Diffuse Multivessel Disease.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Retrograde Percutaneous Recanalization Of Coronary Chronic Total Occlusions: Outcomes And Technical Tips & Tricks From 17 Patients G. BIONDI-ZOCCAI, C.
Featuring CTO Complex-PCI by Trans-radial Approach CTO Case review 5 French TRI CTO of right coronary artery -5 F Launcher guiding Catheter (right Judkins.
Retrograde approach for the Recanalizaiton of Coronary CTO: Preliminary Experience of Single Centre Lei Ge, Juying Qian, Xuebo Liu, Qin Qing, Junbo Ge.
TCT 2012 Revascularization Strategies for Complex Left Main Disease and Left Coronary Ostial Disease Alfredo E. Rodriguez, MD, PhD, FACC, FSCAI Centro.
左主干分叉病变治疗策略的选择 Left main bifurcation: what is the best choice? Lei Ge, MD Department of Cardiology, Zhongshan Hospital, Fudan University.
Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy JOINT SYMPOSIUM WITH JACCT - Bologna, 25/9/2008.
Fu Wai Hospital Jie Qian
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
Chronic Total Occlusions
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Strategies to Improve Inadequate Guide Catheter Support John S Douglas Jr MD S Tanveer Rab MD Emory University School of Medicine Atlanta Georgia Sunday.
Multivessel Coronary Artery Disease
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Retrograde Techniques and the Impact of Operator.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Novel Modification of the Retrograde Approach.
Philippe Généreux, MD for the Tryton Bifurcation Trial Investigators Columbia University Medical Center Cardiovascular Research Foundation New York City.
Total Pageviews - 360,774.
The Endocross Enabler-P: First in-Human Results
Complex Coronary Cases
Viewed in 117 Countries. Viewed in 117 Countries.
G. Capretti, M. Carlino, A. Colombo, L. Azzalini
Complex Coronary Cases
Complex Coronary Cases
Strategies to Improve Inadequate Guide Catheter Support
Complex Coronary Cases
Complex Coronary Cases
The Spectrum of Guidewires Available to Recanalize CTO and How to Choose the Wire/Device Hybrid CTO PCI 2011 Craig A. Thompson, M.D., MMSc. Director, Invasive.
Complex Coronary Cases
The Radial Approach for CTO PCI Utility in the Retrograde and the Antegrade Approaches Shigeru Saito, MD, FACC, FSCAI, FJCC Shonan Kamakura General Hospital.
Treating CTOs Is there evidence based data?
Meruzhan Saghatelyan, MD, Interventional cardiologist
David J. Cohen, M.D., M.Sc. Director of Cardiovascular Research
Complex Coronary Cases
Complex Coronary Cases
CTO Perspectives: When not to Start, and When to Stop and Try Again
Intra-Aortic Balloon Pump For Complex Calcified Left-Main Bifurcation Lesion Supawat Ratanapo, MD Medical College of Georgia, Augusta University.
Complex Coronary Cases
SYNTAX at 2 Years: This Interventionalist’s Perspective
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
Subintimal Tracking and Reentry for CTO STAR Method
Watch our monthly live webcasts from our new and improved website!
CTO Recanalization Highlights from TOPIC Meeting
Essesntials for CTO Recanalization
Newer methods to Facilitate the Retrograde Approach
MACE Trial Rationale, Study Design, and Current Status
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
Fractional Flow Reserve Workshop
Trends in Coronary Procedures per 1000 Medicare Beneficiaries
Catheter-Based Treatment of Coronary Artery Disease
3-Year Clinical Outcomes From the RESOLUTE US Study
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
CHRONIC TOTAL OCCLUSIONS: WHAT IS KNOWN AND
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Maintenance of Long-Term Clinical Benefit with
Atlantic Cardiovascular Patient Outcomes Research Team
Glenn N. Levine et al. JACC 2011;58:e44-e122
Complex Coronary Cases
Presentation transcript:

Complex Coronary Cases Supported by: Abbott Vascular Boston Scientific Corporation Medtronic, Inc. Astrazeneca

Disclosures Samin K. Sharma, MBBS, FACC Speaker’s Bureau – Boston Scientific Corporation, Abbott Vascular Inc, AngioScore, The Medicines Company, Daiichi Sankyo, Inc. and Lilly USA, LLC Annapoorna S. Kini, MBBS, FACC Nothing to disclose Sameer Mehta, MBBS, FACC Consulting Fees – The Medicines Company American College of Cardiology Foundation staff involved with this case have nothing to disclose

Presentation: Patient with new onset cresendo angina and positive stress echo for infero-lateral ischemia underwent cardiac cath on June 26, 2013 which revealed 3 V CAD (60% prox LAD, 80% distal LCx and 100% distal RCA) and normal LV function; SYNTAX score 22. CABG was recommended but declined and pt underwent Resolute Integrity (3.5/30mm) DES PCI of distal LCx. Pt continued to have class II angina on MMT. Prior History: Hypertension, NIDDM, +F/H Medications: All once daily dosage Atenolol 50mg, Amlodipine 5mg, Aspirin 81mg, Prasugrel 5mg, Metformin XR 1000mg, Glimeperide 2mg, Omeprazole 20mg August 20th 2013 Case #14: SD, 62 yr M

Cardiac Cath 6/26/2013: Right Dominance 3 V CAD with LVEF 65% Left Main: No obstruction LAD: 60% prox LAD and 60% D1 non-bifurcation lesions LCx: 80% distal LCx, large vessel RCA: 80% mid and 100% distal RCA occlusion and distal vessel fills via bridge as well as retrograde collaterals Pt underwent successful DES PCI of distal LCx using 3.5/30mm Resolute Integrity DES. Pt did well but had class II angina despite MMT. Did not tolerate ISMN Plan Today: - PCI of distal RCA CTO using retrograde recanalization. Case# 14: cont…

Appropriateness Criteria for Coronary Revascularization

Issues Involving The Case Current status of CTO lesion success Retrograde recanalization approach

Issues Involving The Case Current status of CTO lesion success Retrograde recanalization approach

1. CTO is present in 20-22% of cath cases but PCI is attempted only in 5-13% of these cases 2. From BARI trial (1994) to SYNTAX trial (2007), the single most common reason for a patient to be referred to surgery and not randomized was a CTO with low success rate of recanalization 3. Even in the recent era of increasing success rate of CTO recanalization (60-85%), the PCI success rate for CTO lesions in the SYNTAX trial was only 53% Chronic Total Occlusion (CTO) From Randomized Trials to Daily Practice

Current Perspective on Coronary CTO The Canadian Multicenter CTO Registry Management of CTO Registry Patients by Treating Center Fefer et al, J Am Coll Cardiol 2012;59:991

Anatomic Descriptors of Procedural Success In the current ERA; Severe calcification

Predictors of CTO Procedural Success Multivariate analysis from TOAST-GISE VariablesHazard Ratiop Length ≥15 vs. <8 mm Severe calcification Duration ≥ 180 days Multi-vessel disease Bridge collaterals present Stump morphology Olivari et al., J Am Cardiol Coll 2003;41:1672

Patel et al., JACC Cardiovasc Interv 2013;6:128 Incidence of Procedural Complications in Successful vs. Unsuccessful CTO PCI MACE (%) Death (%)0.41.5< Emergent CABG (%) Stroke (%) MI (%) Q-wave MI (%) Coronary perforation (%) < Tamponade (%)0.01.7< Vascular complication (%) Contrast nephropathy (%) SuccessfulUnsuccessful p value Complications

Patel et al., JACC Cardiovasc Interv 2013;6:128 Temporal Trends in Cumulative Angiographic Success Rates and Major Procedural Complication Rates 80% 0.5%

Meta-Analysis of CTO Outcomes Joyal et al., Am Heart J 2010;160: Observational Studies, 7288 patients weighted averaged follow-up 6 years OR for Success vs. Failure 95% Clp Value Mortality <0.001 MI Subsequent CABG <0.001 Residual Angina

All-Cause Mortality for Successful and Failed Groups of CTO Duration >3 Months Khan et al., Cath & Cardiovasc Intervn 2013;82:95

Residual SYNTAX Score: 1-Year Outcomes According to the rSS Généreux et al., JACC2012;59:2165 Death uTVR MACE MI Stent Thrombosis P = P = 0.23 P =0.32 (%) P = P = rSS = 0 rSS = 0-2 rSS = 3-8 rSS = >8

PCI: Four-Year Clinical Outcomes in Patients by Complete vs. Incomplete Revascularization Patients (%) p=0.059 p=0.052 p=0.23 p=0.046 p=0.011 p=<0.001 Complete Revascularization (n=578) Incomplete Revascularization (n=510) Farooq et. al., J Am Coll Cardiol 2013;61:282

Total Charges, Payments and Direct Costs per Patient Undergoing CTO and Non-CTO PCI Karmpaliotis et al., Cath & Cardiovasc Interv 2013;82:1 Cost ( Dollars ) p=<0.001 p=0.58 CTO (n=154) Non-CTO (n=1,847)

Issues Involving The Case Current status of CTO lesion success Retrograde recanalization approach

Retrograde Wire Technique of CTO Recanalization

Retrograde Techniques for CTO Recanalization Typically reserved for LAD or RCA CTOs via septal collaterals; avoid using epicardial collaterals Four techniques: –Direct retrograde crossing –Kissing wire crossing –Controlled Antegrade and Retrograde Subintimal Tracking (CART); balloon dilatation or knuckle wire –Reverse CART

Retrograde Wire Technique for Chronic Total Occlusion Recanalization Four Patterns of Success in Retrograde CTO Recanalization Sumitsuji et al. J Am Coll Cardiol Intv 2011;4:941.

Increased Use of Retrograde Approach and Technical Success Rate Over Time Michael et al., Am J Cardiol 2013;112:488 % %

Karmpaliotis et al., JACC Cardio Interv 2012;5:1273 Summary of Published Retrograde CTO PCI Series StudyYearN Prior CABG % Septal Collateral Used % Reverse CART, % Technical Success % Major Complic % Flouroscopy Time, min, mean ± SD Contrast Use, ml mean ± SD Sianos NR ± ± 167 Rathore NR NR Kimura ± ± 199 Tsuchikane ± ± 169 Morino NR79.2NR US Registry ±345 ± 177

Retrograde PCI: 5 Steps Retrograde PCI for recanalization of CTOs has gained acceptance as a necessary technique to improve success The procedure involves five key steps: 1. Wiring of the collateral from the donor artery into the distal bed of the recipient artery, usually with the use of hydrophilic jacketed guidewires 2. Delivery of over-the-wire microcatheters especially Corsair channel dilator to allow an exchange for a CTO-specific guidewire 3. Crossing the total occlusion with the CTO guidewire and dilating the CTO with the retrograde small balloon ( /8-10mmsize) 4. Placing an antegrade guidewire into the distal bed through the recanalized CTO. Rarely exteriorization of the long retrograde guidewire (Viper wire 360cm) is needed to advance antegrade monorail or over-the-wire small balloon 5. Stenting the lesion over the antegrade guidewire

Retrograde Wire Technique for CTO Recanalization When to do Retrograde technique? - Minimum 200 CTO cases via antegrade technique - Dedicated setup, equipments and ability to handle compl. - Usually after failed antegrade (once or twice) approach - Ostial stump occlusion (RCA, LAD, LCx)

Procedural Steps of Current CTO-PCI Fundamental Wire Technique and Current Strategy for Chronic Total Occlusion PCI CTO - PCI Antegrade approach x2 Retrograde approach (ostial) IVUS guide re-entry Single Wire Technique Parallel Wire Technique Retrograde Wire Cross Kissing Wire Cross CART Reverse CART SuccessFailure Cotralateral Dual Injection

Take Home Message: Status of CTO lesion PCI and Retrograde recanalization approach Improvement in the procedural techniques and devices has resulted in increasing success of CTO PCI. A successful CTO PCI is associated with better long-term outcome, decreased cost & lower mortality. Technique of retrograde recanalization is gaining increasing momentum and adds to the already increasing technical success rates. Every advanced CTO PCI center should dedicated experienced operators for the retrograde approach.

Which one of the angiographic lesion morphology is associated with the highest rates of unsuccessful CTO recanalization : A. Blunt stump B. Side branch at the site of occlusion C. Short occlusion length D. Severe calcification E. Bridge collaterals Question # 1

A successful CTO recanalization is associated with following except : A. Lower MACE B. Lower mortality C. Lower stent thrombosis D. Lower incidence of long-term CABG E. Lower angina Question # 2

Following are the techniques for retrograde recanalization except : A. Kissing wire approach B. Retrograde wire cross C. Controlled antegrade and retrograde tracking (CART) D. Reverse CART E. Parallel wire technique Question # 3

Which one of the angiographic lesion morphology is associated with the highest rates of unsuccessful CTO recanalization : A. Blunt stump B. Side branch at the site of occlusion C. Short occlusion length D. Severe calcification E. Bridge collaterals Question # 1 The correct answer is D as of these unfavorable factors severe calcification still is associated with highest failure Olivari et al., J Am Cardiol Coll 2003;41:1672.

A successful CTO recanalization is associated with following except : A. Lower MACE B. Lower mortality C. Lower stent thrombosis D. Lower incidence of long-term CABG E. Lower angina Question # 2 The correct answer is C as stent thrombosis may even be higher in successful vs. unsuccessful CTO recanalization Joyal et al., Am Heart J 2010;160:179.

Following are the techniques for retrograde recanalization except : A. Kissing wire approach B. Retrograde wire cross C. Controlled antegrade and retrograde tracking (CART) D. Reverse CART E. Parallel wire technique Question # 3 The correct answer is E as all others are the techniques of retrograde CTO recanalization while the parallel wire technique is for antegrade recanalization Sumitsuji et al. J Am Coll Cardiol Intv 2011;4:941.